World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
41351
World Ranking
5594
National Ranking
3008

Vincent T. Ho publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Vincent T. Ho sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 646 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Vincent T. Ho D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Vincent T. Ho sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Vincent T. Ho is affiliated with Harvard University in the United States, focusing on medical research. Their work primarily spans the field of medicine, with a significant emphasis on hematology, immunology, genetics, oncology, and public health, environmental, and occupational health.

The scientist's research encompasses several specialized subfields, including hematology (116 publications), immunology (61 publications), genetics (43 publications), oncology (25 publications), and public health-related topics (19 publications).

Key topics addressed in their work involve hematopoietic stem cell transplantation, acute myeloid leukemia research, chronic myeloid leukemia treatments, myeloproliferative neoplasms diagnosis and treatment, immune cell function and interaction, acute lymphoblastic leukemia research, and chronic lymphocytic leukemia research. The publication counts for these topics are as follows:

  • Hematopoietic Stem Cell Transplantation: 114 publications
  • Acute Myeloid Leukemia Research: 74 publications
  • Chronic Myeloid Leukemia Treatments: 40 publications
  • Myeloproliferative Neoplasms: Diagnosis and Treatment: 38 publications
  • Immune Cell Function and Interaction: 34 publications
  • Acute Lymphoblastic Leukemia research: 30 publications
  • Chronic Lymphocytic Leukemia Research: 26 publications

The scientist has published extensively in several journals and venues, including:

  • Blood (32 publications)
  • Transplantation and Cellular Therapy (28 publications)
  • Blood Advances (21 publications)
  • Journal of the National Comprehensive Cancer Network (4 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)

Noteworthy recent publications include:

  • Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology, 2020, Journal of the National Comprehensive Cancer Network
  • Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide, 2021, Blood Advances
  • A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation, 2020, Blood
  • Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease, 2020, Journal of Clinical Investigation
  • Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML, 2022, Blood

Frequent collaborators include Robert J. Soiffer (87 co-authored works), Corey Cutler (64 co-authored works), Joseph H. Antin (58 co-authored works), Haesook T. Kim (57 co-authored works), and Mahasweta Gooptu (51 co-authored works).

Best Publications

  • Defining the intensity of conditioning regimens: working definitions.

    Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt

  • High density DNA methylation array with single CpG site resolution

    Marina Bibikova;Bret Barnes;Chan Tsan;Vincent Ho

  • Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough

  • Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

    Christopher E.M. Griffiths;Bruce E. Strober;Peter van de Kerkhof;Vincent Ho

  • Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

    Marta Kulis;Simon Heath;Marina Bibikova;Ana C Queirós

  • Ipilimumab for Patients with Relapse after Allogeneic Transplantation

    Matthew S. Davids;Haesook T. Kim;Pavan Bachireddy;Caitlin Costello

  • The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.

    Vincent T. Ho;Robert J. Soiffer

  • Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

    David B. Miklos;David B. Miklos;Haesook T. Kim;Haesook T. Kim;Katherine H. Miller;Katherine H. Miller;Luxuan Guo;Luxuan Guo

  • Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

    Philippe Armand;Haesook T. Kim;Corey S. Cutler;Vincent T. Ho

  • Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

    Ken-ichi Matsuoka;John Koreth;Haesook T. Kim;O. Gregory Bascug

  • Rituximab for steroid-refractory chronic graft-versus-host disease.

    Corey Cutler;David Miklos;Haesook T. Kim;Nathaniel Treister

  • Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation

    Vincent T. Ho;Corey Cutler;Shelly Carter;Paul Martin

  • Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman

  • Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation

    Rafael Bejar;Kristen E. Stevenson;Bennett Caughey;R. Coleman Lindsley

  • ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

    Mark T. Vander Lugt;Thomas M. Braun;Samir Hanash;Jerome Ritz

  • Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

    Christopher J Gibson;R Coleman Lindsley;Vatche Tchekmedyian;Brenton G Mar

  • Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

    Martha Wadleigh;Paul G. Richardson;David Zahrieh;Stephanie J. Lee

  • Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

    Robert J. Soiffer;Jennifer LeRademacher;Vincent Ho;Fangyu Kan

  • A disease risk index for patients undergoing allogeneic stem cell transplantation

    Philippe Armand;Christopher J. Gibson;Corey Cutler;Vincent T. Ho

  • Double unrelated reduced-intensity umbilical cord blood transplantation in adults

    Karen K. Ballen;Thomas R. Spitzer;Beow Y. Yeap;Steven McAfee

Frequent Co-Authors

Robert J. Soiffer
Robert J. Soiffer Harvard University
Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute
Corey Cutler
Corey Cutler Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
John Koreth
John Koreth Harvard University
Haesook T. Kim
Haesook T. Kim Harvard University
Jerome Ritz
Jerome Ritz Harvard University
Philippe Armand
Philippe Armand Harvard University
Francisco M. Marty
Francisco M. Marty Brigham and Women's Hospital
Bruce R. Blazar
Bruce R. Blazar University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a career in medicine but want flexible education options, there are several online degree pathways worth considering. For those already working as registered nurses, exploring affordable rn to bsn programs can help you quickly upskill and open doors to advanced positions, often with lower tuition rates.

Individuals without a nursing background who wish to enter the field fast may consider direct entry msn programs for non nurses online. These accelerated programs let you earn a master’s degree and begin practice as a nurse without first becoming an RN, saving significant time.

For students looking for easier access to nursing education, direct admit nursing programs are designed to streamline the admissions process, sometimes eliminating prerequisites or competitive requirements.

Alternatively, career-changers might pursue a role in healthcare administration. Training for this important field is available through financial aid for medical billing and coding online classes, making the transition more affordable and accessible for busy adults.

Best Scientists Citing Vincent T. Ho

Trending Scientists

Recently Published Articles